▼Agomelatine for major depressive episodes. Issue 8 (4th August 2010)
- Record Type:
- Journal Article
- Title:
- ▼Agomelatine for major depressive episodes. Issue 8 (4th August 2010)
- Main Title:
- ▼Agomelatine for major depressive episodes
- Abstract:
- Abstract : ▼Agomelatine (Valdoxan - Servier) is an antidepressant licensed for treating patients with major depressive episodes. The drug company's website for agomelatine states that the drug acts simultaneously as a melatonin receptor agonist and a serotonin receptor antagonist and claims that it is a "major therapeutic advance in management of depression through the restoration of circadian rhythms".1 Here we consider whether agomelatine offers significant advantage for patients with major depressive episodes.
- Is Part Of:
- Drug and therapeutics bulletin. Volume 48:Issue 8(2010)
- Journal:
- Drug and therapeutics bulletin
- Issue:
- Volume 48:Issue 8(2010)
- Issue Display:
- Volume 48, Issue 8 (2010)
- Year:
- 2010
- Volume:
- 48
- Issue:
- 8
- Issue Sort Value:
- 2010-0048-0008-0000
- Page Start:
- 93
- Page End:
- 96
- Publication Date:
- 2010-08-04
- Subjects:
- Drugs -- Periodicals
Therapeutics -- Periodicals
Pharmacology -- Periodicals
615.5 - Journal URLs:
- http://dtb.bmj.com/ ↗
http://www.bmj.com/archive ↗ - DOI:
- 10.1136/dtb.2010.08.0043 ↗
- Languages:
- English
- ISSNs:
- 1755-5248
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 18534.xml